HP59

Quality 0.50 · 1 view · Updated 2 months ago

Pathologic angiogenesis capillary endothelial marker protein

title: "HP59" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["proteins"] description: "Pathologic angiogenesis capillary endothelial marker protein" topic_path: "general/proteins" source: "https://en.wikipedia.org/wiki/HP59" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Pathologic angiogenesis capillary endothelial marker protein ::

HP59 is a pathologic angiogenesis capillary endothelial marker protein (7 or 12 transmembrane domains) which has been identified as the receptor for the Group B Streptococcal Toxin (GBS Toxin) molecule known as CM101, the etiologic agent for early-onset versus late-onset Group B Strep.

Expression

Fu, et al. coined the term "pathological angiogenesis" to distinguish between HP59-expressing, and non-HP59-expressing capillaries, however, other researchers have not used this terminology. Therefore it is not yet known whether HP59 is expressed in vasculogenesis, arteriogenesis, sprouting angiogenesis or intussusceptive angiogenesis. However capillaries in all tumor tissues examined were positive for anti-HP59 antibodies and Von Willebrand factor (vWF) antibodies, while in normal tissues only vWF staining was observed.

The target protein for GBStoxin/CM101 is expressed in vasculature of developing organs during their formation during embryogenesis. The lung is the last organ to develop so HP59 is present in the newborn lung for 5–10 days after birth, explaining the susceptibility to GBS induced "early onset" disease. HP59 lectin is expressed later in life only in pathologic angiogenesis, providing a receptor for CM101. The CM101-HP59 complex then activates complement, and initiates an inflammatory cytokine cascade which recruits CD69 positive activated granulocytes to destroy the capillaries and surrounding pathologic tissue. CM101 has been shown in a published Phase I, FDA-approved clinical trial under IND to have clinical safety and effectivity on select stage IV cancer patients, specifically targeting tumor vasculature

HP59 is expressed in the adult in wound healing, and in tumor angiogenesis, as shown in mice.

The gene for HP59 contains, entirely within its coding region, the Sialin Gene SLC17A5 (Solute carrier family 17 (anion/sugar transporter). Member 5, also known asSLC17A5 or sialin is a lysosomal membrane sialic acid transport protein which in humans is encoded by the SLC17A5 gene on Chromosome 6, and appears to be important in CNS myelination. HP59 has a transcription initiation site 300bp upstream of the initiation site for the Sialin Gene SLC17A5, and encodes 41 additional aminoacids at the Amino-terminal. Thus, using an upstream transcription initiation site, and thus a different start codon, HP59, incorporating the Sialin gene product, becomes a pathologic angiogenesis capillary endothelial cell luminal membrane protein with unknown function, which the GBS Toxin CM101 specifically targets. Endothelial involvement is indicated by levels of Soluble E-Selectin.

References

References

  1. (2001). "Identification of a Novel Membrane Protein HP59 with Therapeutic Potential as a Target of Tumor Angiogenesis". Clinical Cancer Research.
  2. (2000). "Isolation and identification of group B β-hemolytic streptococcal (GBS) toxin from septic newborn infants". [[The Journal of Pediatrics]].
  3. (1998). "Functional studies on the anti-pathoangiogenic properties of CM101". Angiogenesis.
  4. (1997). "A phase I study of the antineovascularization drug CM101". J. Clin. Cancer Res..
  5. (2001). "CM101 Stimulates Cutaneous Wound Healing Through an Anti-Angiogenic Mechanism". Angiogenesis.
  6. (1994). "Effects of GBS toxin on long-term survival of mice bearing transplanted Madison lung tumors". J. Cancer Res. Clin. Oncol..
  7. (2013-08-13). "Homo sapiens chromosome 6 genomic contig, GRCh37.p13 Primary Assembly".
  8. [https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=26503]"Entrez Gene: [[SLC17A5]] solute carrier family 17 (anion/sugar transporter), member 5"
  9. (1994). "The genetic locus for free sialic acid storage disease maps to the long arm of chromosome 6". American Journal of Human Genetics.
  10. (1999). "A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases". Nature Genetics.
  11. (2009). "The lysosomal sialic acid transporter sialin is required for normal CNS myelination". J. Neurosci..
  12. (1997). "Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial". J. Cancer Res. Clin. Oncol..

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

proteins